WHITNEY FEICHTNER: Open Payments
NPI 1891203865 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,947 in 271 payments from 33 companies in 2025. Trend: 2023 $3,875 · 2024 $5,190 · 2025 $13,947
Speaker / faculty: $8,450Food & beverage: $4,601Consulting: $675Travel & lodging: $133Education: $88
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 80 | $9,758 |
| ABBVIE INC. | 88 | $1,730 |
| Neurocrine BioSciences, Inc. | 18 | $366 |
| Lundbeck LLC | 8 | $251 |
| UCB, Inc. | 9 | $196 |
| Teva Pharmaceuticals USA, Inc. | 6 | $193 |
| Axsome Therapeutics, Inc. | 6 | $179 |
| ARGENX US, INC. | 7 | $135 |
| Abbott Laboratories | 4 | $91 |
| Amneal Pharmaceuticals LLC | 3 | $87 |
Products named: NURTEC ODT, UBRELVY, BOTOX, QULIPTA, INGREZZA, VYEPTI, Symbravo, Rystiggo.
Industry payments across MO — which companies pay providers there.
